Wockhardt Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹929.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.73 per cent from ₹965.00 crore. This corresponds to a year-on-year *(YoY) growth of 25.88 per cent.
Operating Profit
Operating Profit stands at ₹192.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.67 per cent from ₹225.00 crore. This corresponds to a year-on-year *(YoY) growth of 868.00 per cent.
PBDT
PBDT stands at ₹171.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 29.34 per cent from ₹242.00 crore. This corresponds to a year-on-year *(YoY) growth of 422.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹116.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.62 per cent from ₹189.00 crore. This corresponds to a year-on-year *(YoY) growth of 206.42 per cent.
Net Profit
Net Profit stands at ₹107.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.76 per cent from ₹164.00 crore. This represents a 199.07 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Wockhardt Ltd News
Wockhardt Ltd Earnings
- YOY
- QOQ
Wockhardt Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Wockhardt Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Wockhardt Ltd Financial Reports
Wockhardt Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Wockhardt | 6.20% | 11.64% | 22.82% | 18.65% | 94.44% | 58.05% |
| Glaxosmi. Pharma | 0.21% | 0.99% | -3.36% | 22.09% | 24.05% | 5.38% |
| Gland Pharma | -0.61% | -2.12% | 2.76% | 25.30% | 69.64% | 47.01% |
| Ajanta Pharma | 1.08% | 0.05% | 0.31% | 12.28% | 23.90% | 43.58% |
| Emcure Pharma | 0.51% | -1.47% | 7.56% | 5.54% | 24.62% | 49.74% |
| Sai Life | 1.66% | 1.11% | 11.32% | 32.50% | 59.89% | 83.68% |
| Neuland Labs. | 0.01% | -1.52% | -1.86% | 25.59% | 86.61% | 52.05% |
Company Info
Company Information
Chairman & Exec. Director : H F Khorakiwala
Independent Non Exe. Director : Vineshkumar Jairath
Independent Non Exe. Director : Akhilesh Krishna Gupta
Independent Non Exe. Director : Amelia Fernandes
Independent Non Exe. Director : Ahmad Javed
Independent Non Exe. Director : O P Bhatt
Executive Director : Huzaifa H Khorakiwala
Executive Director & MD : Murtaza H Khorakiwala
Non-Exec & Non-Independent Dir : Zahabiya Habil Khorakiwala
Company Sec. & Compli. Officer : Rashmi Mamtura